Videos Share on Facebook Share on Twitter Share on Pinterest Share on LinkedIn While Biogen rides a big-cap rollercoaster, a few small players are creating better trading opps. Share on Facebook Share on Twitter Share on Pinterest Share on LinkedIn Articles You May Like It’s time now to focus on Nvidia, Treasury bonds and a bullish finish to 2024 Activist ValueAct is poised to trim fat and help boost profits at Meta Platforms. Here’s how Autonomous Vehicles: Why 2025 Will Usher in the Self-Driving Car 5 More Trump Stocks to Trade Nvidia’s stunning 2024 return has all the makings of a stock-market dynasty